Quantbot Technologies’s Day One Biopharmaceuticals DAWN Stock Holding History

Quantbot Technologies’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,101	Closed	-$302K	–	1979
2026 Q1	$302K	Buy	+14,101	New	+$199K	0.01%	1050
2025 Q4	–	Sell	-7,490	Closed	-$52.8K	–	1806
2025 Q3	$52.8K	Sell	7,490 -52	-0.7%	-$358	﹤0.01%	1517
2025 Q2	$49K	Sell	7,542 -2,753	-27%	-$18.9K	﹤0.01%	1485
2025 Q1	$81.6K	Buy	+10,295	New	+$111K	﹤0.01%	1268
2023 Q1	–	Sell	-5,900	Closed	-$127K	–	1656
2022 Q4	$127K	Buy	+5,900	New	+$121K	0.01%	1057
2022 Q3	–	Sell	-2,900	Closed	-$51K	–	1686
2022 Q2	$51K	Buy	+2,900	New	+$29.9K	﹤0.01%	1297

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Quantbot Technologies's DAWN Position: Q2 2026 in Review

Quantbot Technologies sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 14,101 shares — an estimated $302K sold.

Quantbot Technologies first reported a position in DAWN in Q2 2022 and held it in 6 quarters. The position peaked at $302K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Quantbot Technologies reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quantbot Technologies sold 14,101 Day One Biopharmaceuticals shares in Q2 2026, an estimated $302K.
Quantbot Technologies first reported a position in Day One Biopharmaceuticals in Q2 2022 and held it in 6 quarters.
Quantbot Technologies's Day One Biopharmaceuticals position peaked at $302K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.